GB00BSNB6S51 - A14Q2L (XLON)
REDX PHARMA Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | 0,00 % | 0,00 % | -33,51 % | -45,48 % | 60,35 % |
Firmenprofil zu REDX PHARMA Aktie
Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating anti-cancer and fibrosis targets in the areas of unmet medical needs. The company also develops RXC004, a porcupine inhibitor that is in Phase II clinical trial for targeted therapy of Wnt-ligand driven cancer; and RXC007, an oral selective rho associated coiled-coil containing protein kinase 2 (ROCK2) inhibitor for the treatment of fibrotic diseases. In addition, it develops gastrointestinal targeted ROCK inhibitor to treat crohn's disease-associated fibrosis; discoidin domain receptors (DDRs) inhibitor for the treatment of multiple fibrotic conditions; and RXC006, a porcupine inhibitor targeting fibrotic diseases, including idiopathic pulmonary fibrosis. The company has a research collaboration agreement with Jazz Pharmaceuticals plc to discover and develop drug candidates for two cancer targets in the Ras/Raf/MAP kinase pathway. Redx Pharma Plc was incorporated in 2010 and is based in Macclesfield, the United Kingdom.
Unternehmensdaten zur REDX PHARMA Aktie
Name REDX PHARMA
Firma Redx Pharma Plc
Website https://www.redxpharma.com
Heimatbörse
London
WKN A14Q2L
ISIN GB00BSNB6S51
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Ms. Lisa Mary Whewell Anson
Marktkapitalisierung 58 Mio
Land Großbritannien und Nordirland
Währung GBP
Mitarbeiter 0,1 T
Adresse Alderley Park, SK10 4TG Macclesfield
IPO Datum 2015-03-27
Ticker Symbole
Name | Symbol |
---|---|
London | REDX.L |
Weitere Aktien
Investoren die REDX PHARMA halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024